Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Liabilities and Shareholders Equity: 2013-2025

Historic Liabilities and Shareholders Equity for Phibro Animal Health (PAHC) over the last 13 years, with Jun 2025 value amounting to $1.4 billion.

  • Phibro Animal Health's Liabilities and Shareholders Equity rose 43.39% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year increase of 37.15%. This contributed to the annual value of $1.4 billion for FY2025, which is 38.56% up from last year.
  • Phibro Animal Health's Liabilities and Shareholders Equity amounted to $1.4 billion in FY2025, which was up 38.56% from $982.2 million recorded in FY2024.
  • Phibro Animal Health's 5-year Liabilities and Shareholders Equity high stood at $1.4 billion for FY2025, and its period low was $841.3 million during FY2021.
  • In the last 3 years, Phibro Animal Health's Liabilities and Shareholders Equity had a median value of $982.2 million in 2024 and averaged $1.1 billion.
  • Data for Phibro Animal Health's Liabilities and Shareholders Equity shows a peak YoY skyrocketed of 38.56% (in 2025) over the last 5 years.
  • Over the past 5 years, Phibro Animal Health's Liabilities and Shareholders Equity (Yearly) stood at $841.3 million in 2021, then rose by 10.74% to $931.7 million in 2022, then increased by 4.26% to $971.4 million in 2023, then rose by 1.11% to $982.2 million in 2024, then skyrocketed by 38.56% to $1.4 billion in 2025.